MARK2 and Alzheimer disease: Once active, MARK2 can phosphorylate tau at four residues within the MT binding region (MTBR) (Ser-262, Ser-293, Ser-324, and Ser-356) (36) and was shown to colocalize with tau in AD brain (37).